Stock Market Today, Feb.: ImmunityBio Surges on Anktiva
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Weighing expense ratio against tax efficiency helps determine impact on returns. This guide provides a practical approach to prioritizing factors.
28,166 articlesBiotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
A focused look at a nuclear energy stock with small modular reactors (SMRs) at the center. Learn the potential upside...
Nike stands as a global powerhouse, but recent pressure has investors asking, should Nike stock? This guide lays out ...
The software market's laggard this year may be near a tipping point. Snowflake's recent performance hints that AI-dri...
Meta launches a $3.99 monthly Instagram Plus plan, delivering longer stories and advanced metrics as part of a broade...
June brought a high-stakes move in AI infrastructure funding. Super Micro Computer announced a $7B equity financing p...
Public figures face a financial balancing act around exclusive conferences. This piece uses sophia bush defends dialo...
Could SpaceX stock reach $192 by 2027? This guide lays out the drivers, the math behind the target, and realistic ste...
Adobe has faced a significant stock drop, but a lower price isn’t the same as a bargain. This guide breaks down what ...
AMD delivered a blockbuster quarter, topping expectations on both earnings and revenue. The market response was elect...
June brought a tech-focused pullback as Apple raised device prices to offset memory costs. This deep dive explains wh...
Investors are watching Friday’s April payroll report for signs that businesses really starting hire signals a broader...